Nifty

:

17843.15

Sensex

:

60614.72

121.65 (0.69%)
328.68 (0.55%)

Login

Nifty
Sensex

:
:

17843.15
60614.72

121.65 (0.69%)
328.68 (0.55%)

Sequent Scientific Ltd.

Pharmaceuticals & Drugs - Veterinary

Rating :

28/99

BSE: 512529 | NSE: SEQUENT

Watchlist

NSE BSE

73.60

08-Feb-2023

Day's Open
Day's High
Day's Low
Previous Close

72.05
74.20
70.75
71.70

Volume
Traded Value (lacs)
52 Week High
52 Week Low

932132
673.09
162.75
70.60

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

1,838.32
216.55
2

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

2,093.96
N/A
2.43

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

15.76
6.51
6.21

EBITDA CAGR (%)

10 Years
5 Years
3 Years

-4.05
-0.38
-8.47

PAT CAGR (%)

10 Years
5 Years
3 Years

-
-37.18
-16.13

P:E (Median)

8 Years
5 Years
3 Years

29.24
49.67
62.00

P:BV (Average)

8 Years
5 Years
3 Years

4.57
4.10
5.19

EV:EBITDA (Average)

8 Years
5 Years
3 Years

41.60
21.04
24.77

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone

Description Sep 22 Sep 21 Var% Jun 22 Jun 21 Var% Mar 22 Mar 21 Var% Dec 21 Dec 20 Var%
Net Sales 54.23 50.11 8.22% 64.86 46.66 39.01% 63.67 69.48 -8.36% 59.19 68.46 -13.54%
Expenses 63.81 54.69 16.68% 66.85 50.82 31.54% 58.46 66.60 -12.22% 56.41 55.81 1.08%
EBITDA -9.58 -4.58 - -1.99 -4.16 - 5.21 2.88 80.90% 2.78 12.65 -78.02%
EBIDTM -17.66% -9.14% -3.07% -8.92% 8.19% 4.14% 4.70% 18.48%
Other Income 6.73 10.41 -35.35% 5.88 5.76 2.08% 5.77 5.92 -2.53% 5.70 5.67 0.53%
Interest 0.57 0.28 103.57% 0.35 0.17 105.88% 0.61 0.25 144.00% 0.56 0.60 -6.67%
Depreciation 2.25 2.54 -11.42% 2.38 2.31 3.03% 2.34 2.61 -10.34% 2.40 2.19 9.59%
PBT -5.68 3.01 - 1.16 -0.87 - 8.04 6.03 33.33% 5.52 15.53 -64.46%
Tax -1.63 -1.28 - 0.32 -0.26 - 1.39 1.39 0.00% 1.04 3.80 -72.63%
PAT -4.05 4.29 - 0.84 -0.61 - 6.65 4.64 43.32% 4.47 11.72 -61.86%
PATM -7.47% 8.56% 1.30% -1.31% 10.44% 6.68% 7.56% 17.13%
EPS -0.16 0.17 - 0.03 -0.02 - 0.27 0.19 42.11% 0.18 0.47 -61.70%

Description Sep 22 Sep 21 Var% Jun 22 Jun 21 Var% Mar 22 Mar 21 Var% Dec 21 Dec 20 Var%
Net Sales 337.61 350.55 -3.69% 341.32 320.51 6.49% 383.71 361.82 6.05% 358.05 355.06 0.84%
Expenses 334.74 330.87 1.17% 339.21 300.35 12.94% 350.36 318.54 9.99% 321.83 290.54 10.77%
EBITDA 2.87 19.68 -85.42% 2.12 20.16 -89.48% 33.35 43.28 -22.94% 36.22 64.52 -43.86%
EBIDTM 0.85% 5.61% 0.62% 6.29% 8.69% 11.96% 10.12% 18.17%
Other Income 0.91 0.74 22.97% 0.88 2.67 -67.04% 3.77 1.37 175.18% 3.67 2.81 30.60%
Interest 8.12 3.26 149.08% 6.80 3.02 125.17% 6.04 3.18 89.94% 3.45 6.20 -44.35%
Depreciation 13.38 13.21 1.29% 12.56 12.57 -0.08% 12.47 12.68 -1.66% 12.83 11.58 10.79%
PBT -17.72 3.95 - -19.57 7.23 - 18.61 29.01 -35.85% 23.61 49.55 -52.35%
Tax -13.28 -9.88 - -5.16 4.58 - 8.57 5.49 56.10% 5.05 11.57 -56.35%
PAT -4.44 13.82 - -14.41 2.65 - 10.04 23.52 -57.31% 18.56 37.98 -51.13%
PATM -1.32% 3.94% -4.22% 0.83% 2.62% 6.50% 5.18% 10.70%
EPS -0.15 0.58 - -0.56 0.04 - 0.36 0.83 -56.63% 0.69 1.43 -51.75%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description TTM Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13
Net Sales 241.95 219.63 265.46 227.33 166.26 271.20 105.87 394.59 444.82 445.08 235.77 Net Sales Growth 3.08% -17.26% 16.77% 36.73% -38.69% 156.16% -73.17% -11.29% -0.06% 88.78% Cost Of Goods Sold 141.11 108.66 108.87 113.04 94.62 161.37 72.47 218.33 229.86 245.55 133.20 Gross Profit 100.84 110.97 156.59 114.29 71.64 109.83 33.40 176.26 214.95 199.53 102.57 GP Margin 41.68% 50.53% 58.99% 50.27% 43.09% 40.50% 31.55% 44.67% 48.32% 44.83% 43.50% Total Expenditure 245.53 231.59 241.50 205.10 163.57 258.06 121.27 359.06 384.54 437.81 253.85 Power & Fuel Cost - 11.96 12.77 12.73 8.52 2.32 2.14 17.98 20.68 21.77 17.98 % Of Sales - 5.45% 4.81% 5.60% 5.12% 0.86% 2.02% 4.56% 4.65% 4.89% 7.63% Employee Cost - 27.38 22.42 17.10 10.71 25.12 17.90 38.84 45.47 42.87 29.10 % Of Sales - 12.47% 8.45% 7.52% 6.44% 9.26% 16.91% 9.84% 10.22% 9.63% 12.34% Manufacturing Exp. - 48.21 58.70 51.52 41.13 15.87 14.85 56.50 48.54 49.63 34.33 % Of Sales - 21.95% 22.11% 22.66% 24.74% 5.85% 14.03% 14.32% 10.91% 11.15% 14.56% General & Admin Exp. - 16.29 15.28 6.90 7.15 13.02 9.92 15.19 23.99 41.71 14.93 % Of Sales - 7.42% 5.76% 3.04% 4.30% 4.80% 9.37% 3.85% 5.39% 9.37% 6.33% Selling & Distn. Exp. - 2.16 4.02 2.11 1.04 0.83 0.47 4.03 5.71 7.90 7.03 % Of Sales - 0.98% 1.51% 0.93% 0.63% 0.31% 0.44% 1.02% 1.28% 1.77% 2.98% Miscellaneous Exp. - 16.94 19.45 1.68 0.40 39.53 3.53 8.19 10.29 28.37 7.03 % Of Sales - 7.71% 7.33% 0.74% 0.24% 14.58% 3.33% 2.08% 2.31% 6.37% 7.33% EBITDA -3.58 -11.96 23.96 22.23 2.69 13.14 -15.40 35.53 60.28 7.27 -18.08 EBITDA Margin -1.48% -5.45% 9.03% 9.78% 1.62% 4.85% -14.55% 9.00% 13.55% 1.63% -7.67% Other Income 24.08 38.86 31.30 14.56 13.96 24.67 19.07 15.55 3.56 5.25 2.92 Interest 2.09 1.61 2.68 5.04 3.22 4.54 0.42 16.44 47.46 38.74 24.64 Depreciation 9.37 9.59 9.13 8.95 7.22 14.37 3.25 24.18 26.38 27.13 23.00 PBT 9.04 15.69 43.45 22.81 6.20 18.90 -0.01 10.46 -9.99 -53.34 -62.81 Tax 1.12 0.89 8.77 1.47 -1.38 2.87 0.00 0.07 1.70 0.00 -8.31 Tax Rate 12.39% 5.67% 21.45% 6.44% -22.26% 0.70% 0.00% 0.67% 3.95% 0.00% 13.23% PAT 7.91 14.80 32.11 21.34 7.59 406.41 -0.01 10.39 41.31 -114.42 -54.50 PAT before Minority Interest 7.91 14.80 32.11 21.34 7.59 406.41 -0.01 10.39 41.31 -114.42 -54.50 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 3.27% 6.74% 12.10% 9.39% 4.57% 149.86% -0.01% 2.63% 9.29% -25.71% -23.12% PAT Growth -60.53% -53.91% 50.47% 181.16% -98.13% - - -74.85% - - EPS 0.32 0.59 1.29 0.86 0.30 16.30 0.00 0.42 1.66 -4.59 -2.19

Description TTM Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13
Net Sales 1,420.69 1,412.82 1,361.62 1,179.24 1,039.31 1,030.59 683.57 624.98 465.36 455.46 326.86 Net Sales Growth 2.36% 3.76% 15.47% 13.46% 0.85% 50.77% 9.37% 34.30% 2.17% 39.34% Cost Of Goods Sold 820.91 792.99 694.65 605.05 543.01 554.23 356.70 311.71 240.72 243.65 181.72 Gross Profit 599.78 619.82 666.96 574.19 496.30 476.36 326.87 313.27 224.65 211.81 145.14 GP Margin 42.22% 43.87% 48.98% 48.69% 47.75% 46.22% 47.82% 50.12% 48.27% 46.50% 44.40% Total Expenditure 1,346.14 1,303.43 1,151.68 1,008.92 914.37 919.10 643.03 568.27 444.87 438.68 342.51 Power & Fuel Cost - 33.86 28.75 24.73 23.06 14.66 12.77 26.51 23.32 22.06 23.53 % Of Sales - 2.40% 2.11% 2.10% 2.22% 1.42% 1.87% 4.24% 5.01% 4.84% 7.20% Employee Cost - 231.37 187.22 165.06 145.95 132.07 106.22 88.62 62.39 48.12 41.47 % Of Sales - 16.38% 13.75% 14.00% 14.04% 12.81% 15.54% 14.18% 13.41% 10.57% 12.69% Manufacturing Exp. - 93.67 96.18 83.24 77.73 59.07 57.63 72.14 54.31 52.30 41.42 % Of Sales - 6.63% 7.06% 7.06% 7.48% 5.73% 8.43% 11.54% 11.67% 11.48% 12.67% General & Admin Exp. - 66.90 58.40 56.37 58.35 70.92 48.60 36.44 33.79 43.58 23.96 % Of Sales - 4.74% 4.29% 4.78% 5.61% 6.88% 7.11% 5.83% 7.26% 9.57% 7.33% Selling & Distn. Exp. - 57.11 50.00 45.16 36.29 36.87 28.78 17.46 20.27 12.30 10.51 % Of Sales - 4.04% 3.67% 3.83% 3.49% 3.58% 4.21% 2.79% 4.36% 2.70% 3.22% Miscellaneous Exp. - 27.52 36.47 29.32 29.98 51.29 32.34 15.40 10.07 16.66 10.51 % Of Sales - 1.95% 2.68% 2.49% 2.88% 4.98% 4.73% 2.46% 2.16% 3.66% 6.09% EBITDA 74.56 109.39 209.94 170.32 124.94 111.49 40.54 56.71 20.49 16.78 -15.65 EBITDA Margin 5.25% 7.74% 15.42% 14.44% 12.02% 10.82% 5.93% 9.07% 4.40% 3.68% -4.79% Other Income 9.23 10.86 10.49 10.09 8.67 17.20 11.08 14.30 9.96 3.84 4.96 Interest 24.41 15.77 24.38 35.71 32.80 39.70 28.34 38.56 44.37 39.04 33.45 Depreciation 51.24 51.09 50.60 50.62 41.92 53.30 40.07 46.22 32.94 32.60 28.61 PBT 4.93 53.39 145.45 94.08 58.88 35.70 -16.80 -13.77 -46.85 -51.00 -72.75 Tax -4.82 8.33 32.18 12.03 2.01 13.46 -0.41 2.62 3.39 0.58 -8.06 Tax Rate -97.77% 15.60% 23.55% 12.79% 3.41% 3.03% 2.44% -19.03% -40.50% -0.53% 11.08% PAT 9.75 41.25 95.44 69.91 48.66 421.57 -13.83 -18.47 -10.74 -110.49 -64.69 PAT before Minority Interest 8.28 45.06 104.45 82.05 56.88 430.83 -16.39 -16.39 -11.76 -110.49 -64.69 Minority Interest -1.47 -3.81 -9.01 -12.14 -8.22 -9.26 2.56 -2.08 1.02 0.00 0.00 PAT Margin 0.69% 2.92% 7.01% 5.93% 4.68% 40.91% -2.02% -2.96% -2.31% -24.26% -19.79% PAT Growth -87.50% -56.78% 36.52% 43.67% -88.46% - - - - - EPS 0.39 1.65 3.83 2.80 1.95 16.90 -0.55 -0.74 -0.43 -4.43 -2.59

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13
Shareholder's Funds 1,041.09 1,029.51 886.22 917.79 948.62 1,257.33 1,205.88 156.92 50.25 109.45 Share Capital 49.67 49.67 49.67 49.37 48.75 48.75 47.65 30.48 26.74 23.44 Total Reserves 944.32 972.07 822.45 849.53 882.29 1,193.03 1,134.19 92.50 11.15 74.13 Non-Current Liabilities 19.26 4.80 11.50 36.20 19.01 38.28 42.08 79.95 109.66 113.91 Secured Loans 0.00 0.00 15.16 20.61 0.00 13.98 23.82 56.70 90.47 107.52 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.35 0.56 0.72 Long Term Provisions 24.51 6.59 4.09 22.30 24.39 28.88 22.84 22.97 18.70 5.68 Current Liabilities 89.56 96.62 105.24 79.87 26.69 168.71 109.89 427.45 414.42 319.83 Trade Payables 57.56 58.75 64.34 52.60 24.56 69.96 73.64 69.81 135.38 145.92 Other Current Liabilities 5.20 2.85 9.30 6.01 1.91 35.29 20.85 86.85 31.38 27.75 Short Term Borrowings 15.50 5.22 14.39 19.27 0.00 63.22 15.04 270.29 241.08 139.47 Short Term Provisions 11.30 29.81 17.22 1.99 0.21 0.24 0.36 0.51 6.58 6.70 Total Liabilities 1,149.91 1,130.93 1,002.96 1,033.86 994.32 1,464.32 1,357.85 664.32 574.33 543.19 Net Block 66.90 65.78 69.41 52.42 23.68 181.67 169.60 200.88 219.93 205.10 Gross Block 113.09 102.86 99.30 73.33 37.61 230.34 193.00 302.01 338.33 301.32 Accumulated Depreciation 46.19 37.08 29.89 20.90 13.93 48.67 23.40 101.13 118.40 96.22 Non Current Assets 995.04 985.95 879.01 946.46 853.77 1,095.85 1,056.39 421.95 333.95 321.05 Capital Work in Progress 1.40 4.34 3.72 0.03 3.12 32.26 19.97 8.93 11.12 21.51 Non Current Investment 658.47 685.11 738.95 788.16 672.67 834.62 834.87 183.11 65.04 54.57 Long Term Loans & Adv. 267.65 230.43 65.53 83.27 138.79 26.79 23.08 26.30 36.20 38.56 Other Non Current Assets 0.61 0.29 1.39 22.57 15.51 20.52 8.86 2.73 1.66 1.30 Current Assets 154.86 144.99 123.95 87.41 140.54 368.46 301.47 242.38 240.38 222.13 Current Investments 0.14 0.07 18.75 0.10 13.98 62.28 62.29 0.08 0.08 0.18 Inventories 67.99 45.79 31.42 25.33 13.83 62.53 56.19 66.88 101.25 82.67 Sundry Debtors 52.42 61.44 40.79 42.90 78.47 113.03 73.75 98.77 79.66 70.16 Cash & Bank 12.89 0.74 3.72 1.88 3.04 3.06 4.80 27.38 19.13 31.07 Other Current Assets 21.43 3.56 3.61 1.56 31.22 127.56 104.45 49.28 40.26 38.05 Short Term Loans & Adv. 19.69 33.40 25.66 15.65 30.09 114.68 86.38 30.28 36.32 32.06 Net Current Assets 65.31 48.37 18.71 7.54 113.85 199.75 191.58 -185.08 -174.04 -97.69 Total Assets 1,149.90 1,130.94 1,002.96 1,033.87 994.31 1,464.31 1,357.86 664.33 574.33 543.18

Description Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13
Shareholder's Funds 692.41 727.65 687.10 706.69 647.58 976.79 945.71 91.27 56.73 95.00 Share Capital 49.67 49.67 49.67 49.37 48.75 48.75 47.65 30.48 26.74 23.44 Total Reserves 595.64 670.21 623.34 638.43 581.25 912.49 874.01 26.85 -0.37 59.68 Non-Current Liabilities 199.33 153.58 216.46 214.75 227.13 246.20 299.72 277.55 159.23 144.35 Secured Loans 87.25 62.52 108.88 126.94 85.14 141.76 197.50 249.97 150.52 137.32 Unsecured Loans 35.21 31.18 41.18 20.90 18.40 23.38 13.82 0.35 0.56 0.72 Long Term Provisions 55.95 27.19 13.16 30.50 28.54 34.76 28.66 25.70 8.03 6.09 Current Liabilities 537.35 513.11 514.86 440.41 430.93 663.55 290.37 406.09 405.28 345.41 Trade Payables 258.05 226.91 220.38 209.35 160.49 203.04 143.94 90.94 114.59 150.91 Other Current Liabilities 78.99 100.64 104.98 87.80 106.52 259.26 83.23 107.43 56.80 35.63 Short Term Borrowings 159.54 102.91 147.12 127.36 152.41 194.70 56.04 204.31 226.60 151.76 Short Term Provisions 40.77 82.66 42.38 15.90 11.51 6.54 7.17 3.42 7.29 7.12 Total Liabilities 1,477.10 1,443.00 1,463.16 1,402.10 1,342.62 1,903.76 1,538.02 921.84 625.82 589.34 Net Block 554.97 535.66 576.57 498.14 475.97 684.33 586.48 474.43 237.59 227.26 Gross Block 816.26 753.25 762.46 638.06 581.74 789.60 643.70 596.25 369.07 330.69 Accumulated Depreciation 261.29 217.60 185.89 139.91 105.77 105.27 57.22 121.82 131.48 103.43 Non Current Assets 665.16 676.33 738.86 795.99 804.61 1,176.02 1,047.48 612.00 359.87 358.31 Capital Work in Progress 11.63 30.79 13.42 22.61 18.04 32.55 23.52 39.06 43.04 88.71 Non Current Investment 36.79 76.94 131.29 179.65 221.73 363.97 360.58 58.04 0.04 1.64 Long Term Loans & Adv. 53.92 32.15 14.40 32.27 31.01 37.51 30.35 36.01 76.06 39.28 Other Non Current Assets 7.85 0.79 3.18 63.31 57.86 57.66 46.54 4.47 3.15 1.42 Current Assets 811.93 766.68 724.30 606.12 538.01 727.74 490.54 309.84 265.94 231.04 Current Investments 1.44 5.66 40.18 0.47 17.34 64.12 66.98 0.58 0.08 0.18 Inventories 347.97 264.36 219.42 200.10 158.57 160.81 135.08 94.36 101.40 85.62 Sundry Debtors 329.24 346.14 318.76 278.25 258.35 254.62 192.39 115.44 83.54 65.81 Cash & Bank 59.25 56.20 75.83 72.04 42.45 47.40 25.30 38.46 36.21 33.00 Other Current Assets 74.03 16.82 14.79 8.51 61.30 200.79 70.80 61.01 44.71 46.44 Short Term Loans & Adv. 66.35 77.52 55.33 46.75 56.05 54.48 46.69 41.86 37.47 36.48 Net Current Assets 274.58 253.57 209.44 165.71 107.08 64.19 200.17 -96.25 -139.34 -114.37 Total Assets 1,477.09 1,443.01 1,463.16 1,402.11 1,342.62 1,903.76 1,538.02 921.84 625.81 589.35

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13
Cash From Operating Activity 9.36 2.34 30.20 73.80 -4.02 -24.04 100.02 -24.99 -42.37 -12.70 PBT 15.69 43.45 22.81 6.20 409.27 -0.01 10.46 43.01 -114.42 -62.81 Adjustment -6.38 1.12 1.74 -2.19 -392.74 20.30 33.58 22.54 136.20 61.04 Changes in Working Capital 1.81 -25.47 7.84 70.32 -21.10 -42.97 56.92 -89.22 -63.80 -11.41 Cash after chg. in Working capital 11.12 19.09 32.39 74.34 -4.57 -22.68 100.95 -23.68 -42.01 -13.18 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -1.75 -16.76 -2.19 -0.54 0.55 -1.36 -0.93 -1.31 -0.35 0.48 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -4.25 16.55 -17.68 -114.06 15.60 -46.84 -359.41 23.65 -60.82 -31.29 Net Fixed Assets -7.29 -4.18 -29.66 -32.63 221.87 -49.63 97.97 38.51 -26.62 -28.82 Net Investments 26.57 72.52 30.56 -101.61 210.25 0.26 -713.97 -118.07 -10.37 -15.66 Others -23.53 -51.79 -18.58 20.18 -416.52 2.53 256.59 103.21 -23.83 13.19 Cash from Financing Activity 7.25 -21.33 -10.71 40.34 -11.78 70.97 247.38 7.96 107.56 38.81 Net Cash Inflow / Outflow 12.36 -2.44 1.81 0.07 -0.19 0.09 -12.01 6.62 4.37 -5.17 Opening Cash & Equivalents 0.44 2.87 1.07 1.00 1.19 1.10 13.11 6.48 2.11 7.29 Closing Cash & Equivalent 12.80 0.44 2.87 1.07 1.00 1.19 1.10 13.10 6.48 2.11

Description Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13
Cash From Operating Activity 30.59 114.75 115.33 116.02 45.24 -7.19 -0.05 -23.55 -44.78 -3.82 PBT 53.39 145.45 94.08 58.88 445.79 -16.80 -13.77 -8.37 -109.91 -72.75 Adjustment 93.27 83.98 91.41 84.47 -313.85 123.31 83.81 35.92 133.52 65.98 Changes in Working Capital -89.30 -70.89 -58.30 -27.95 -77.87 -104.37 -71.46 -53.98 -67.45 2.48 Cash after chg. in Working capital 57.36 158.55 127.18 115.40 54.06 2.14 -1.42 -26.44 -43.84 -4.28 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -26.77 -43.79 -11.85 0.62 -8.83 -9.33 1.37 2.89 -0.95 0.46 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -95.57 9.65 -72.27 -67.69 7.17 -116.18 -315.83 -154.69 -79.95 -54.89 Net Fixed Assets -7.29 -4.18 -29.66 -32.63 221.87 -49.63 97.97 38.51 -26.62 -28.82 Net Investments 26.57 72.52 30.56 -101.61 210.25 0.26 -713.97 -118.07 -10.37 -15.66 Others -114.85 -58.69 -73.17 66.55 -424.95 -66.81 300.17 -75.13 -42.96 -10.41 Cash from Financing Activity 67.26 -138.75 -42.75 -20.08 -56.96 147.44 308.69 179.41 145.54 34.70 Net Cash Inflow / Outflow 2.29 -14.35 0.31 28.25 -4.55 24.07 -7.19 1.17 20.80 -24.02 Opening Cash & Equivalents 53.74 68.10 67.79 39.54 44.10 20.03 21.85 22.96 3.45 27.37 Closing Cash & Equivalent 57.50 53.74 68.10 67.79 39.54 44.10 20.03 21.83 22.96 3.45

Financial Ratios

Consolidated /

Standalone

Right to Left

Description Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13
Book Value (Rs.) 40.02 41.14 35.11 36.41 38.20 50.95 49.61 8.07 2.83 8.33 ROA 1.30% 3.01% 2.10% 0.75% 33.06% 0.00% 1.03% 6.67% -20.48% -10.34% ROE 1.47% 3.39% 2.41% 0.83% 37.41% 0.00% 1.59% 51.35% -168.93% -48.60% ROCE 1.65% 4.45% 2.96% 0.99% 36.09% 0.03% 3.07% 20.15% -19.54% -10.55% Fixed Asset Turnover 2.04 2.66 2.66 3.00 2.05 0.52 1.65 1.45 1.45 0.85 Receivable days 94.31 69.43 66.55 132.93 127.17 310.76 77.04 70.28 58.94 113.28 Inventory Days 94.25 52.44 45.13 42.89 50.71 197.54 54.96 66.23 72.35 108.19 Payable days 195.35 206.34 103.60 86.82 78.05 239.99 74.47 102.24 128.36 197.86 Cash Conversion Cycle -6.79 -84.46 8.08 88.99 99.83 268.31 57.53 34.27 2.92 23.61 Total Debt/Equity 0.02 0.01 0.04 0.05 0.00 0.07 0.04 2.77 9.23 2.72 Interest Cover 10.75 16.26 5.53 2.93 91.09 0.97 1.64 1.91 -1.95 -1.55

Description Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13
Book Value (Rs.) 25.98 28.98 27.10 27.86 25.85 39.44 38.69 3.76 1.97 7.09 ROA 3.09% 7.19% 5.73% 4.14% 26.54% -0.95% -1.33% -1.52% -18.19% -11.23% ROE 6.60% 15.00% 12.06% 8.63% 54.15% -1.74% -3.35% -28.10% -201.83% -62.91% ROCE 7.06% 16.24% 12.59% 9.24% 41.28% 0.87% 2.72% 6.93% -16.09% -9.86% Fixed Asset Turnover 1.80 1.80 1.72 1.74 1.51 0.96 1.03 1.01 1.36 1.08 Receivable days 87.24 89.12 90.45 92.53 90.49 118.40 87.75 74.80 57.30 72.70 Inventory Days 79.10 64.84 63.56 61.85 56.34 78.37 65.41 73.58 71.75 82.12 Payable days 111.61 117.51 80.72 75.36 77.04 104.11 77.28 87.31 115.68 149.32 Cash Conversion Cycle 54.73 36.45 73.29 79.02 69.78 92.66 75.87 61.07 13.36 5.51 Total Debt/Equity 0.49 0.31 0.51 0.47 0.48 0.43 0.34 8.26 15.86 3.74 Interest Cover 4.38 6.60 3.63 2.80 12.19 0.41 0.64 0.81 -1.82 -1.18

Top Investors:

ashoka india opportunities fund

icici lombard general insurance company ltd

investor education and protection fund (iepf)

Annual Reports:

News Update:

Sequent Scientific gets nod to acquire 100% stake in Tineta Pharma
8th Nov 2022, 12:58 PM

The Board of Directors of the Company at their meeting held on November 7, 2022, has considered and approved the same
Read More
Sequent Scientific - Quarterly Results
7th Nov 2022, 20:36 PM

Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback